{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:36:44Z","timestamp":1760834204446,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.trim.2020.101305","type":"journal-article","created":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T04:11:11Z","timestamp":1588824671000},"page":"101305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Outcome of donor lymphocyte infusion for fall in chimerism after hematopoietic stem cell transplant"],"prefix":"10.1016","volume":"61","author":[{"given":"Prashant","family":"Pandey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divya","family":"Setya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esha","family":"Kaul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shweta","family":"Ranjan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Praveen","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.trim.2020.101305_bb0005","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1200\/JCO.2000.18.3.547","article-title":"Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia","volume":"18","author":"Kantarjian","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.trim.2020.101305_bb0010","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1182\/blood-2006-02-001933","article-title":"Allogeneic stem cell transplantation for patients with chronic myeloid leukemia and acute lymphocytic leukemia after Bcr-Abl kinase mutation related imatinib failure","volume":"108","author":"Jabbour","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.trim.2020.101305_bb0015","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/sj.bmt.1705889","article-title":"Unrelated donor allogeneic transplantation for adult acute lymphoblastic leukemia: a review","volume":"41","author":"Bachanova","year":"2008","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.trim.2020.101305_bb0020","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1182\/blood-2006-04-019836","article-title":"Prophylactic administration of imatinib after hematopoietic cell transplantation for high-risk Philadelphia chromosome-positive leukemia","volume":"109","author":"Carpenter","year":"2007","journal-title":"Blood."},{"key":"10.1016\/j.trim.2020.101305_bb0025","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11912-006-0056-y","article-title":"Philadelphia chromosome-positive acute lymphoblastic leukemia: impact of imatinib treatment on remission induction and allogeneic stem cell transplantation","volume":"8","author":"Kovacsovics","year":"2006","journal-title":"Curr. Oncol. Rep."},{"issue":"11","key":"10.1016\/j.trim.2020.101305_bb0030","first-page":"1612","article-title":"Successful treatment with imatinib-combined chemotherapy for relapsed Philadelphia-positive acute lymphoblastic leukemia after allogeneic bone marrow transplantation","volume":"50","author":"Imahashi","year":"2009","journal-title":"Rinsho Ketsueki."},{"key":"10.1016\/j.trim.2020.101305_bb0035","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/sj.bmt.1702596","article-title":"Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: lower incidence of acute graft-versus-host disease and improved outcome","volume":"26","author":"Shiobara","year":"2000","journal-title":"Bone Marrow Transplant."},{"issue":"4","key":"10.1016\/j.trim.2020.101305_bb0040","article-title":"Ph-positive leukemias in the era of modern cytogenetics, molecular biology, tyrosine kinase inhibitors and hematopoietic stem cell transplantation","volume":"1","author":"Mamaev","year":"2010","journal-title":"Cell. Therap. Transplant"},{"issue":"2","key":"10.1016\/j.trim.2020.101305_bb0045","doi-asserted-by":"crossref","first-page":"S195","DOI":"10.1016\/j.bbmt.2012.11.207","article-title":"Evaluating donor lymphocyte infusions (DLI) for the treatment of falling chimerism, minimal residual disease and relapse after pediatric hematopoietic stem cell transplantation (HSCT)","volume":"19","author":"El-Bietar","year":"2013","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.trim.2020.101305_bb0050","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.leukres.2008.03.031","article-title":"Nilotinib and donor lymphocyte infusion in the treatment of Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL) relapsing after allogeneic stem cell transplantation and resistant to imatinib","volume":"33","author":"Tiribelli","year":"2009","journal-title":"Leuk. Res."},{"key":"10.1016\/j.trim.2020.101305_bb0055","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/sj.bmt.1702555","article-title":"Donor leukocyte infusions in acute lymphocytic leukemia","volume":"26","author":"Collins","year":"2000","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.trim.2020.101305_bb0060","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1182\/blood-2003-02-0342","article-title":"Graft-versus-leukemia reactions in allogeneic chimeras","volume":"103","author":"Kolb","year":"2004","journal-title":"Blood."},{"issue":"1","key":"10.1016\/j.trim.2020.101305_bb0065","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3324\/haematol.2019.219790","article-title":"Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMT","volume":"105","author":"Dholaria","year":"2020","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.trim.2020.101305_bb0070","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.bbmt.2013.11.020","article-title":"HLA-haploidentical donor lymphocyte infusions for patients with relapsed hematologic malignancies after related HLA-haploidentical bone marrow transplantation","volume":"20","author":"Zeidan","year":"2014","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"1","key":"10.1016\/j.trim.2020.101305_bb0075","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/bmt.2014.217","article-title":"DLI after haploidentical BMT with post-transplant CY","volume":"50","author":"Ghiso","year":"2015","journal-title":"Bone Marrow Transplant."},{"issue":"12","key":"10.1016\/j.trim.2020.101305_bb0080","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1038\/bmt.2017.193","article-title":"Donor-lymphocyte infusion following haploidentical hematopoietic cell transplantation with peripheral blood stem cell grafts and PTCy","volume":"52","author":"Goldsmith","year":"2017","journal-title":"Bone Marrow Transplant."}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096632742030023X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096632742030023X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T17:59:21Z","timestamp":1760810361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096632742030023X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":16,"alternative-id":["S096632742030023X"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2020.101305","relation":{},"ISSN":["0966-3274"],"issn-type":[{"type":"print","value":"0966-3274"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcome of donor lymphocyte infusion for fall in chimerism after hematopoietic stem cell transplant","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2020.101305","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101305"}}